Ruth Connor of Symbiora Inc. in the U.S. will evaluate the safety and effectiveness of a low-cost oral solution derived from beneficial strains of human gut bacteria to prevent and treat acute diarrheal illness in infants.
Grant ID
OPP1025506
Show on Hub
On
Show on Spoke
On
Follow-on Funding
Off
Lead Funding Organization
Initiatives
Principal Investigator
Award Manager
Individual Funder Information
Funding Organization
Funding Amount (in original currency)
100000.00
Funding Currency
USD
Funding Amount (in USD)
100000.00
Project Type
Project Primary Sector
Funding Date Range
-
Funding Total (In US dollars)
100000.00
Co-Funded
False